Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Neurogene Inc (NASDAQ: NGNE) was $20.09 for the day, up 1.72% from the previous closing price of $19.75. In other words, the price has increased by $1.72 from its previous closing price. On the day, 75550.0 shares were traded. NGNE stock price reached its highest trading level at $20.71 during the session, while it also had its lowest trading level at $19.01.
Ratios:
Our analysis of NGNE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.03 and its Current Ratio is at 21.03. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on June 17, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
On May 16, 2025, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $24.
On June 27, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $65.BMO Capital Markets initiated its Outperform rating on June 27, 2024, with a $65 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 14 ’25 when Cobb Stuart sold 6,797 shares for $15.15 per share. The transaction valued at 103,003 led to the insider holds 20,794 shares of the business.
STUART COBB bought 6,797 shares of NGNE for $105,421 on May 14 ’25. On Mar 13 ’25, another insider, Cvijic Christine Mikail, who serves as the President and CFO of the company, sold 4,501 shares for $16.94 each. As a result, the insider received 76,247 and left with 72,343 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NGNE now has a Market Capitalization of 286525600 and an Enterprise Value of -67677112. For the stock, the TTM Price-to-Sale (P/S) ratio is 308.10 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at -73.164 whereas that against EBITDA is 0.782.
Stock Price History:
The Beta on a monthly basis for NGNE is 1.64, which has changed by -0.4113683 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, NGNE has reached a high of $74.49, while it has fallen to a 52-week low of $6.88. The 50-Day Moving Average of the stock is 14.30%, while the 200-Day Moving Average is calculated to be -18.11%.
Shares Statistics:
NGNE traded an average of 268.59K shares per day over the past three months and 295680 shares per day over the past ten days. A total of 14.93M shares are outstanding, with a floating share count of 11.75M. Insiders hold about 17.63% of the company’s shares, while institutions hold 100.31% stake in the company. Shares short for NGNE as of 1749772800 were 2245516 with a Short Ratio of 8.36, compared to 1747267200 on 2696233. Therefore, it implies a Short% of Shares Outstanding of 2245516 and a Short% of Float of 19.98.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
